We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
-0.83%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$3.01B
Cap. Flow
+$3.35B
Cap. Flow %
30.64%
Top 10 Hldgs %
32.26%
Holding
2,911
New
179
Increased
662
Reduced
956
Closed
673

Top Buys

Rank Stock Value
1
PCAR icon
PACCAR
PCAR
+$588M
2
IDEV icon
iShares Core MSCI International Developed Markets ETF
IDEV
+$263M
3
MSFT icon
Microsoft
MSFT
+$243M
4
DIHP icon
Dimensional International High Profitability ETF
DIHP
+$184M
5
VTI icon
Vanguard Total Stock Market ETF
VTI
+$135M

Top Sells

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$732M
2
NVDA icon
NVIDIA
NVDA
+$99.5M
3
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$37.5M
4
USHY icon
iShares Broad USD High Yield Corporate Bond ETF
USHY
+$21.6M
5
ULTA icon
Ulta Beauty
ULTA
+$19.3M

Sector Composition

Rank Sector Weight
1 Technology 9.57%
2 Industrials 9.07%
3 Financials 5.38%
4 Consumer Discretionary 4.16%
5 Healthcare 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASIX icon
2101
AdvanSix
ASIX
$566M
$586 ﹤0.01%
24
-4
-14% -$76
BLKB icon
2102
Blackbaud
BLKB
$1.5B
$580 ﹤0.01%
15
-112
-88% -$5.59K
PK icon
2103
Park Hotels & Resorts
PK
$2.99B
$580 ﹤0.01%
55
-706
-93% -$7.8K
JAZZ icon
2104
Jazz Pharmaceuticals
JAZZ
$16B
$568 ﹤0.01%
3
-21
-88% -$3.67K
OLMA icon
2105
Olema Pharmaceuticals
OLMA
$1.02B
$567 ﹤0.01%
38
-5
-12% -$111
BCRX icon
2106
BioCryst Pharmaceuticals
BCRX
$2.4B
$566 ﹤0.01%
59
+55
+1,375% +$427
RVLV icon
2107
Revolve Group
RVLV
$1.77B
$566 ﹤0.01%
25
– –
PAYS icon
2108
Paysign
PAYS
$486M
$561 ﹤0.01%
95
– –
ARTY
2109
iShares Future AI & Tech ETF
ARTY
$3.53B
$560 ﹤0.01%
12
– –
TSLY icon
2110
YieldMax TSLA Option Income Strategy ETF
TSLY
$604M
$540 ﹤0.01%
18
– –
NLR icon
2111
VanEck Uranium + Nuclear Energy ETF
NLR
$3.92B
$533 ﹤0.01%
4
– –
URA icon
2112
Global X Uranium ETF
URA
$5.54B
$533 ﹤0.01%
11
– –
BBIO icon
2113
BridgeBio Pharma
BBIO
$16.6B
$520 ﹤0.01%
7
– –
CHH icon
2114
Choice Hotels
CHH
$5.06B
$518 ﹤0.01%
5
-59
-92% -$6.13K
XP icon
2115
XP
XP
$8.7B
$515 ﹤0.01%
27
-55
-67% -$1.06K
TEVA icon
2116
Teva Pharmaceuticals
TEVA
$36B
$513 ﹤0.01%
17
– –
CRON
2117
Cronos Group
CRON
$1.05B
$502 ﹤0.01%
200
– –
TAK icon
2118
Takeda Pharmaceutical
TAK
$55.2B
$463 ﹤0.01%
25
– –
NIO icon
2119
NIO
NIO
$11.4B
$462 ﹤0.01%
77
– –
DEFT
2120
Defi Technologies
DEFT
$156M
$451 ﹤0.01%
815
– –
CHRS icon
2121
Coherus Oncology
CHRS
$221M
$449 ﹤0.01%
266
-3
-1% -$5
RDNT icon
2122
RadNet
RDNT
$4.87B
$448 ﹤0.01%
8
-1,113
-99% -$76K
VIRT icon
2123
Virtu Financial
VIRT
$5.22B
$440 ﹤0.01%
10
– –
PTON icon
2124
Peloton Interactive
PTON
$2.64B
$429 ﹤0.01%
100
-11
-10% -$54
MIND icon
2125
MIND Technology
MIND
$51.4M
$418 ﹤0.01%
50
– –
83 84
85
86 87

Similar funds

HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BMSSC
B. Metzler seel. Sohn & Co Frankfurt, Germany $10.8B AUM 21.99% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

Clearstead Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Clearstead Advisors held 2,911 positions worth $10.9B, up 38% from $7.93B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Clearstead Advisors deployed $3.35B of net new capital in Q1 2026, opening 179 new positions and adding to 662 existing holdings. Its largest new stake was Dimensional International High Profitability ETF: 5,528,400 shares worth $178M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, down from 12% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $37.5M trimmed.

  • Clearstead Advisors's largest Q1 2026 buy was Dimensional International High Profitability ETF: 5,528,400 shares worth $178M.
  • Clearstead Advisors added most to PACCAR in Q1 2026, an estimated $588M increase.
  • Clearstead Advisors's biggest Q1 2026 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $37.5M.
  • Clearstead Advisors fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $732M.
  • Clearstead Advisors's ten largest holdings make up 32% of its $10.9B portfolio in Q1 2026.
  • Clearstead Advisors opened 179 new positions and closed 673 in Q1 2026.
  • Clearstead Advisors's portfolio value rose 38% quarter-over-quarter to $10.9B.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.